Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of rupatadine fumarate oral solution in children with allergic rhinitis
CTR20244954Phase 3Completed
- Sponsor
- Brothers Enterprises Holding
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rupatadine in allergic rhinitis (AR), sponsored by Brothers Enterprises Holding. Started Dec 2024; status: completed.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20244954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244954.